Aortic arch calcification and bone-associated molecules in peritoneal dialysis patients
Blood Purification Apr 06, 2019
Tsukada M, et al. - Researchers examined 30 continuous ambulatory peritoneal dialysis (CAPD) patients (age 49.3 ± 13.4 years), to determine aortic arch calcification (AoAC) progression-related molecules in these subjects. They used plain chest radiography scoring (AoACS) to determine AoAC. Increased AoACS on follow-up chest X-ray at the end of the study (progressors) was accepted as the definition of AoAC progression. They assessed fibroblast growth factor-23 and osteoprotegerin (OPG). Participants were followed for a median duration of 38.5 months. Findings revealed a link between increased aortic stiffness and AoAC progression. In this patient population, a possible link between OPG and AoAC progression was also suggested.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries